Genetically driven variation in serotonin uptake:: Is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?

被引:286
作者
Lesch, KP [1 ]
Mössner, R [1 ]
机构
[1] Univ Wurzburg, Dept Psychiat, D-97080 Wurzburg, Germany
关键词
serotonin transporter; affective disorders; anxiety disorders; alcoholism; schizophrenia; autism; Alzheimer's disease;
D O I
10.1016/S0006-3223(98)00121-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Serotonin (5-HT) is an important regulator of morphogenetic activities during early central nervous system development, including cell proliferation, migration, and differentiation. The 5-HT transporter (5-HTT) plays a pivotal role in brain 5-HT homeostasis. It is also the initial target for both antidepressant drugs and drugs of abuse, some of which are potent neurotoxins. A polymorphism in the 5'-flanking regulatory region of the 5-HTT gene that results in allelic variation of 5-HTT expression is associated with anxiety-related personality traits and may influence the risk of developing affective disorders. Progress in 5-HTT gene inactivation studies are also changing views of the relevance of adaptive 5-HT uptake function in brain development and plasticity as well as processes underlying drug dependence and neurodegeneration. Despite evidence for a potential role of the 5-HTT in the integra lion of synaptic connections in the mammalian brain during development, adult life, and old age, detailed knowledge of the molecular mechanisms involved in these fine-tuning processes is just beginning to emerge. Integration of various strategies, including molecular genetic, transgenic, and gene transfer techniques, will allow elucidation of the 5-HTT's role in brain development, plasticity, and degeneration as well as in affective illness, drug abuse, and dementia. (C) 1998 Society of Biological Psychiatry.
引用
收藏
页码:179 / 192
页数:14
相关论文
共 84 条
[1]  
Altemus M, 1996, AM J MED GENET, V67, P409, DOI 10.1002/(SICI)1096-8628(19960726)67:4<409::AID-AJMG16>3.0.CO
[2]  
2-N
[3]   THE HYPERSEROTONEMIA OF AUTISM [J].
ANDERSON, GM ;
HORNE, WC ;
CHATTERJEE, D ;
COHEN, DJ .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 600 :331-342
[4]   AUTISM AS A STRONGLY GENETIC DISORDER - EVIDENCE FROM A BRITISH TWIN STUDY [J].
BAILEY, A ;
LECOUTEUR, A ;
GOTTESMAN, I ;
BOLTON, P ;
SIMONOFF, E ;
YUZDA, E ;
RUTTER, M .
PSYCHOLOGICAL MEDICINE, 1995, 25 (01) :63-77
[5]   SEROTONIN-MEDIATED ENDOCYTOSIS OF APCAM - AN EARLY STEP OF LEARNING-RELATED SYNAPTIC GROWTH IN APLYSIA [J].
BAILEY, CH ;
CHEN, M ;
KELLER, F ;
KANDEL, ER .
SCIENCE, 1992, 256 (5057) :645-649
[6]   The serotonin transporter gene and peer-rated neuroticism [J].
Ball, D ;
Hill, L ;
Freeman, B ;
Eley, TC ;
Strelau, J ;
Riemann, R ;
Spinath, FM ;
Angleitner, A ;
Plomin, R .
NEUROREPORT, 1997, 8 (05) :1301-1304
[7]   Gene structure and 5'-flanking regulatory region of the murine serotonin transporter [J].
Bengel, D ;
Heils, A ;
Petri, S ;
Seemann, M ;
Glatz, K ;
Andrews, A ;
Murphy, DL ;
Lesch, KP .
MOLECULAR BRAIN RESEARCH, 1997, 44 (02) :286-292
[8]   Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice [J].
Bengel, D ;
Murphy, DL ;
Andrews, AM ;
Wichems, CH ;
Feltner, D ;
Heils, A ;
Mössner, R ;
Westphal, H ;
Lesch, KP .
MOLECULAR PHARMACOLOGY, 1998, 53 (04) :649-655
[9]   Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene [J].
Billett, EA ;
Richter, MA ;
King, N ;
Heils, A ;
Lesch, KP ;
Kennedy, JL .
MOLECULAR PSYCHIATRY, 1997, 2 (05) :403-406
[10]  
BLAKELY RD, 1994, J EXP BIOL, V196, P263